Results 101 to 110 of about 23,836 (161)

Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers. [PDF]

MAbs
Liu Y, Peng H, Fan X, Liu X, Jiao G, Li J, Wang T, Fong SJ, Zhu L, Dai Y, Zhao Q.   +10 more
europepmc   +1 more source

Isolation and Characterisation of Phage-Displayed scFv Antibodies Targeting PfHSP70 and PfLDH of <i>Plasmodium falciparum</i>. [PDF]

Biochem Res Int
Gasa NL, Zuma LK, Chiliza TE, Kwezi L, Luthuli SD, Pooe OJ.   +5 more
europepmc   +1 more source

Potent Cross-Serotype Dengue Neutralization with Low ADE by AG-Strand-Targeting Anti-EDIII Antibodies. [PDF]

ACS Omega
Nilchan N, Phungsom A, Tantiwatcharakunthon M, Luangaram P, Pakchotanon P, Duangchinda T, Kraivong R, Prommool T, Srisawat C, Puttikhunt C.   +9 more
europepmc   +1 more source

Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model. [PDF]

Neurotherapeutics
Al Ojaimi Y, Dupuis A, Palla M, Lanznaster D, Hergesheimer R, Galineau L, Serriere S, Chami AA, Martineau P, Alouane T, Marouillat S, Dupuy C, Schneider BL, Veyrat-Durebex C, Masse F, Trovero F, Andres CR, Corcia P, Vourcʼh P, Blasco H.   +19 more
europepmc   +1 more source

PD-L1-targeted OMV priming licenses myeloid co-stimulation and chemokine circuits to potentiate CAR-T therapy in advanced-stage solid tumors. [PDF]

J Nanobiotechnology
Yang Y, Peng J, Wei J, Qin J, Jiao Y, Liu M, Wang G.   +6 more
europepmc   +1 more source

The Canonical Wnt Surrogate Agonist scFv-Dkk1c Ameliorates Spinal Cord Injury in Rats. [PDF]

Mol Neurobiol
González P, Maqueda A, González-Fernández C, Sánchez-Gutiérrez T, Pérez V, Rodríguez FJ.   +5 more
europepmc   +1 more source

Nonclinical safety assessment of SBT777101, a CAR-engineered regulatory T cell therapy for autoimmune diseases. [PDF]

Toxicol Sci
Lebrec H, Clingan JM, van der Vuurst de Vries AR, Mihalcik L, Honaker Y, Charmsaz S, Dura S, Hooper KA, Xiao Y, Blake M, Fiebiger M, Dhayal R, Saechao C, Iannello A, Ramsdell F, Bluestone JA, Beilke J.   +16 more
europepmc   +1 more source

Engineering CAR-Tregs with Phage-Selected scFv Enables a New Paradigm for Immune Regulation. [PDF]

Bioessays
Noyan F, Hardtke-Wolenski M.
europepmc   +1 more source

Fully human antagonistic antibodies targeting FPR2 through dual extracellular-loop engagement for gastric cancer therapy. [PDF]

Antib Ther
Kim MS, Kang TH.
europepmc   +1 more source

Improving purity and apparent thermal stability of single-chain Fv antibodies by heat treatment in a soluble E. coli cytoplasmic expression system. [PDF]

J Biochem
De S, Kobashigawa Y, Okazaki K, Kamesawa S, Sato T, Morioka H.   +5 more
europepmc   +1 more source